Newsgather
BackFDA shuffles top drug, biologics leaders in latest shakeup
NOTICIA
CNBC16.05.2026Business

FDA shuffles top drug, biologics leaders in latest shakeup

Tamaño de fuente

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

Continue reading on CNBC
This article was originally published by CNBC.

Noticias relacionadas

Stocks Rebound as Investors Shrug Off U.S.-Iran Tensions; Meta Ramps Up AI, FedEx Launches Healthcare Unit
En desarrollo·9 sa önce

Stocks Rebound as Investors Shrug Off U.S.-Iran Tensions; Meta Ramps Up AI, FedEx Launches Healthcare Unit

Stocks rebounded Thursday, with the S&P 500 gaining nearly 1% and the Nasdaq jumping over 1%, as investors dismissed concerns about U.S.-Iran conflict escalation. Meta Platforms plans to aggressively ramp up AI compute capacity, releasing its strongest model yet, Muse Park 1.1, with an API for developers. FedEx launched a dedicated healthcare unit, while Starbucks aims to use AI for in-house software tools.

CNBC